| Amaranthus caudatus |
Amaranthus caudatus |
Activity |
68.0 |
% |
10.1016/j.ejmech.2018.03.043 |
| Aspergillus fumigatus |
Chitinase |
IC50 |
1000000.0 |
nM |
10.1016/j.bmc.2010.09.062 |
| Electrophorus electricus |
Acetylcholinesterase |
Inhibition |
-5.12 |
% |
10.1016/j.bmc.2012.09.040 |
| Equus caballus |
Cholinesterase |
Inhibition |
3.13 |
% |
10.1016/j.bmc.2012.09.040 |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Acidic mammalian chitinase |
IC50 |
1000000.0 |
nM |
10.1016/j.bmc.2010.09.062 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
3431.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Arachidonate 15-lipoxygenase |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
7943.28 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
10000.0 |
nM |
None |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
25118864.3 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Geminin |
Potency |
58.0 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
819.9 |
nM |
None |
| Homo sapiens |
HeLa |
Activity |
4.9 |
% |
None |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
0.43 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
12.19 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
HL-60 |
IC50 |
21900.0 |
nM |
10.1016/j.bmcl.2007.01.033 |
| Homo sapiens |
Hypoxia-inducible factor 1 alpha |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
NHDF |
Activity |
nan |
None |
10.1016/j.ejmech.2018.03.043 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serine/threonine-protein kinase PINK1, mitochondrial |
Activity |
nan |
None |
10.1021/acs.jmedchem.6b01897 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
96.48 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
100.56 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Survival motor neuron protein |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
THP-1 |
Activity |
106.87 |
% |
10.1016/j.ejmech.2018.02.018 |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
5011.9 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
6991.3 |
nM |
10.1038/s41467-023-40064-9 |
| Mus musculus |
RAW264.7 |
Inhibition |
-19.51 |
% |
10.1016/j.ejmech.2018.02.018 |
| Mus musculus |
RAW264.7 |
Inhibition |
45.94 |
% |
10.1016/j.ejmech.2018.02.018 |
| Nicotiana tabacum |
Nicotiana tabacum |
Activity |
101.0 |
% |
10.1016/j.ejmech.2018.03.043 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
9285.0 |
nM |
None |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Saccharomyces cerevisiae S288c |
Endochitinase |
Ki |
3200.0 |
nM |
10.1016/j.bmc.2010.09.062 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
-3.89 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.2348 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.06 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
3.99 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.01403 |
None |
10.1101/2020.04.03.023846 |
| Triticum aestivum |
Triticum aestivum |
Activity |
98.0 |
% |
10.1016/j.ejmech.2018.03.043 |
| None |
ADMET |
Ct |
2.97 |
uM |
10.1039/D1MD00113B |
| None |
ADMET |
logPapp |
-6.0 |
None |
10.1016/j.bmc.2021.115993 |
| None |
ADMET |
Papp |
7.6 |
10^-6 cm/s |
10.1016/j.bmc.2021.115993 |
| None |
ADMET |
Papp |
16.3 |
10^-6 cm/s |
10.1016/j.bmc.2021.115993 |
| None |
ADMET |
PPB |
12.9 |
% |
10.1016/j.bmc.2021.115993 |
| None |
ADMET |
Stability |
78.0 |
% |
10.1016/j.bmc.2021.115993 |
| None |
ADMET |
Stability |
83.0 |
% |
10.1016/j.bmc.2021.115993 |
| None |
NON-PROTEIN TARGET |
Potency |
1677.4 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
10583.9 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
23694.5 |
nM |
None |
| None |
No relevant target |
Activity |
0.71 |
equiv |
10.1016/j.ejmech.2018.03.043 |
| None |
Platelet |
Inhibition |
nan |
% |
10.1016/j.bmcl.2014.10.080 |
| None |
Unchecked |
Activity |
nan |
None |
None |
| None |
Unchecked |
Potency |
7943.3 |
nM |
None |
| None |
Unchecked |
Potency |
11220.2 |
nM |
None |
| None |
Unchecked |
Potency |
15848.9 |
nM |
None |